期刊文献+

氯吡格雷对动脉粥样硬化家兔炎症因子的影响 被引量:7

Effect of clopidogrel on inflammation in atherosclerotic rabbits
下载PDF
导出
摘要 目的:观察氯吡格雷对动脉粥样硬化(AS)家兔血清高敏C-反应蛋白(hs-CRP)和血管壁核因子-κB(NF-κB)水平的影响。方法:27只新西兰雄性白兔随机分为正常对照组(NC)、高胆固醇组(HC)和高胆固醇加氯吡格雷组(HC+C)。采用固相酶联免疫吸附试验(ELISA)定量测定血清hs-CRP及主动脉弓血管壁NF-κB含量;组织形态学分析AS斑块/内膜面积比值及斑块最厚处内/中膜厚度比值。结果:HC+C组与HC组相比,斑块/内膜的面积比下降39.59%,内膜/中膜厚度比下降41.57%(P<0.01);血管壁NF-κB及血清hs-CRP含量亦明显降低(P<0.05)。结论:氯吡格雷具有抗AS作用和抗炎作用。 OBJECTIVE To observe the effects of ADP receptor blocker clopidogrel on the levels of serum (hs CRP) and nuclear factor-kappa B(NF-κB) in atherosclerotic plaque in rabbit models. METHODS Twenty-seven New Zealand male rabbits were randomly divided into normal control group(NC group, n = 9), high-cholesterol group( HC group, n = 9) and high-cholesterol plus clopidogrel group(HC + C group, n = 9) and then were fed for 12 weeks, enzyme-linked immunosorbent assay (ELISA) was employed to monitor the levels of serum hs-CRP and plaque tissue NF-κB in vascular wall, the plaque area of aor ta and the neointima thickness were performed with histomorphometry analysis. RESULTS The levels of serum hs-CRP and vascular wall NF-κB p65 subunit, the neointima thickness and plaque area of aorta in the HC group and HC+ C group were sig nificantly increased compared with the NC group(P〈0. 05). There was no significantly difference in the serum lipids between the HC group and HC + C group(P〉0. 05), the levels of serum hs-CRP and vascular wall NF-κB p65, the neointima thickness and plaque area of aorta in the HC+ C group were significantly decreased compared with the NC group(P〈0. 05). CONCLUSION The study suggested that clopidogel could decrease atherosclerosis and inflammation.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第13期1074-1077,共4页 Chinese Journal of Hospital Pharmacy
关键词 动脉粥样硬化 氯吡格雷 高敏D反应蛋白 核因子-ΚB atherosclerosis clopidogrel inflammation hs-CRP nuclear factor-kappa B
  • 相关文献

参考文献8

  • 1Ross R. Atherosclerosis an inflammatory disease[J]. N Engl J Med, 1999,340:115-126.
  • 2Patrono C, Luis A, Rodriguez G,et al. Low-dose aspirin for the prevention of atherothrombosis[J]. N Engl J Med, 2005,353 : 2373-2383.
  • 3Herbert JM, Tissinier A, Defreyn G, et al. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler Thromb[J]. Vasc Biol, 1993,13:1171.
  • 4Lutgens E, Daemen MJ. CD40-CD40L interactions in athero sclerosis[J]. Trend Cardiovasc Med, 2002,12 ( 1 ) :27-32.
  • 5Gawaz M, Neumann FJ, Dickfeld T, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells[J]. Circulation, 1998, 98 : 1164 -1171.
  • 6Brand K, Page S, Rogler G,et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J]. J Clin lnvest, 1996,97(7) : 1715-1722.
  • 7Wilson SH, Caplice NM, Simari RD, et al. Activated nuclear factor kappa B is present in the coronary vasculature in experimental hypercholesterolemia [J]. Atherosclrosis, 2000, 148 (1):23.
  • 8Hattori Y, Matsumura M, Kasai KK, et al. Vascular smooth muscle cell activation by C-reactive protein[J]. Cardiovas Res, 2003,58 : 186-195.

同被引文献30

  • 1李崇剑,高润霖,杨跃进,陈纪林.易损斑块的病理生理机制及其检测的研究进展[J].中华心血管病杂志,2004,32(6):570-573. 被引量:88
  • 2赵凤兰.舒降之、低分子肝素、氯比格雷联合治疗不稳定型心绞痛的疗效观察[J].临床医学,2005,25(5):6-7. 被引量:14
  • 3张焕轶,周发展,王伯松,王咏梅,李惠娟,尹鲁骅.长期应用氯吡格雷对冠心病患者血管内皮功能的影响[J].中国动脉硬化杂志,2006,14(11):986-988. 被引量:4
  • 4罗俊,燕纯伯.瑞舒伐他汀抗动脉粥样硬化的临床应用进展[J].心血管病学进展,2007,28(3):480-483. 被引量:53
  • 5Luo Y,Jiang DY.Changes in serum imerleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndeome and their responses to simvastatin[J].Heart Vessels,2004,19(6):257-262.
  • 6Tonstad S,Sundfor T,Seljeflot I.Effect of lifestyle changes on atherogenie lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease[J].AMJ Cardiol,2005,95(10):1187-1191.
  • 7Yusuf S,Hawken S,Upuu S,et al.Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries,a case-controlled study[J].Lancet,2005,366(9497):1640-1649.
  • 8Yusuf S, HaWKens,Upaus,et al. Okesity and the risk of myocardial infarction in 27. 000 participants from 52 countries, a case controlled study[J]. I.ancet,2005,366(9497) :1640-1649.
  • 9Yusuf S.HaWKens.Upaus.et al.Okesity and the risk of myocardial infarction in 27.000 participants from 52 countries,a case-controlled study.Lancet,2005,366(9497):1640-1649.
  • 10Yusuf S,HaWKens,Upaus,et al.Okesity and the risk of myocardial infarction in 27.000 participants from 52 countries,a case-controlled study[J].Lanc et,2005,366(9497):1640-1649.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部